Back
 

View:
Mini 
BasicThis view is available after user registration.
 
ShortThis view is available when you buy a license.
 
StandardThis view is available when you buy a license.
 
CompleteThis view is available when you buy a license.
 

Pembrolizumab 200, Breast Cancer, Second Line

Protocol-ID: 1329 V1.0 (Mini), PEMB200, Breast Ca, second line

Indication(s)

  • Breast Cancer (tripel negative); ICD-10 C50.-
The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti.

Valid since: 06.09.2019